# Liver regeneration: cytokine regulation targeting hepatocytes and beyond

**Authors:** Ting Xiao, Zhangliu Jin, Jiangming Deng, Wen Meng

PMC · DOI: 10.1093/lifemedi/lnag004 · 2026-01-29

## TL;DR

This paper reviews how cytokines and metabolic changes regulate liver regeneration, offering insights into potential therapies for liver diseases.

## Contribution

The paper provides a comprehensive review of cytokine and metabolic pathways in liver regeneration, highlighting novel therapeutic strategies.

## Key findings

- Cytokines from non-parenchymal cells and systemic cues regulate hepatocyte proliferation.
- Metabolic reprogramming supports liver regeneration through glucose, lipid, and amino acid adaptations.
- Targeting cytokine networks and metabolic pathways offers new therapeutic opportunities for liver diseases.

## Abstract

The liver, the largest glandular organ in humans, exhibits a unique and robust regenerative capacity following injury. This regenerative response is orchestrated through a highly regulated network of cellular and molecular signals. Here, we review the cytokine-mediated regulation of liver regeneration, emphasizing autocrine, paracrine, as well as endocrine pathways. Hepatocyte proliferation is modulated not only by intrinsic signals but also by cytokines derived from non-parenchymal cells—including Kupffer cells, hepatic stellate cells, and liver sinusoidal endothelial cells—as well as by endocrine cues from the systemic circulation. From the perspective of metabolic reprogramming, these regulatory pathways illustrate how adaptive changes in glucose, lipid, and amino acid metabolism collectively sustain the cellular activities essential for liver regeneration. We further explore how metabolic adaptations contribute to regeneration, providing mechanistic insights and revealing potential therapeutic targets for liver diseases. Finally, we discuss emerging strategies that target cytokine networks and metabolic pathways to enhance liver regeneration, highlighting recent advances in translational applications.

## Full-text entities

- **Diseases:** liver diseases (MESH:D008107)
- **Chemicals:** glucose (MESH:D005947), lipid (MESH:D008055), amino acid (MESH:D000596)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12978310/full.md

---
Source: https://tomesphere.com/paper/PMC12978310